Benitec Biopharma (BNTC) Balance Sheet: Assets & Liabilities

Benitec Biopharma (BNTC) Balance Sheet

As of Jun 30, 2026 (end of fiscal 2026), Benitec Biopharma reported total assets of $182.62M and total liabilities of $5.61M. Shareholders' equity was $177.01M, up 81.9% from $97.30M a year earlier. Total debt stood at $762.00K against $179.97M in cash and short-term investments, a net cash position of $179.21M. That puts debt-to-equity at 0.00, compared with 0.01 a year earlier.

Benitec Biopharma Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Benitec Biopharma Inc. (BNTC) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017
Current Assets
Cash and Cash Equivalents	179.97	97.74	50.87	2.48	4.06	19.77	9.80	22.48	16.17	17.44
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.08
Cash & Short-Term Investments	179.97	97.74	50.87	2.48	4.06	19.77	9.80	22.48	16.20	17.44
Accounts Receivable	0.00	0.03	0.23	0.06	0.00	0.03	0.06	5.25	4.27	3.49
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.07
Other Current Assets	1.60	0.74	0.58	1.18	0.76	0.81	0.95	-0.90	0.54	1.37
Total Current Assets	181.69	98.52	51.67	3.73	4.82	20.61	10.81	26.83	21.00	22.24
Non-Current Assets
Property, Plant & Equipment (Net)	0.87	0.99	0.45	0.61	0.99	0.58	0.77	0.47	0.23	0.34
Other Non-Current Assets	0.07	0.08	0.09	0.10	0.16	0.19	0.01	0.22	0.21	0.16
Total Non-Current Assets	0.94	1.07	0.54	0.74	1.15	0.77	0.94	0.69	0.45	0.51
Total Assets	182.62	99.59	52.21	4.46	5.97	21.38	11.74	27.51	21.45	22.75
Current Liabilities
Accounts Payable	0.91	0.20	4.17	1.14	1.88	0.88	0.28	1.47	0.43	0.13
Short-Term Debt	0.50	0.35	0.28	0.28	0.25	0.21	0.19	0.00	0.00	0.00
Accrued Liabilities	2.53	0.43	0.48	2.02	0.40	0.28	-	-	-	-
Other Current Liabilities	3.94	1.25	2.64	1.82	1.16	0.39	0.66	1.16	2.13	0.73
Total Current Liabilities	5.34	1.80	4.92	3.98	2.53	1.37	1.14	2.64	2.56	0.86
Non-Current Liabilities
Long-Term Debt	0.27	0.50	0.00	0.28	0.56	0.00	0.21	0.00	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.16	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.04	0.04
Total Non-Current Liabilities	0.27	0.50	0.04	0.28	0.56	0.00	0.37	0.00	0.04	0.04
Total Liabilities	5.61	2.30	4.96	4.26	3.09	1.37	1.51	2.64	2.61	0.89
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	120.54	156.14
Retained Earnings	-273.72	-228.18	-190.26	-167.89	-148.33	-130.12	-116.64	-108.87	-107.86	-136.24
Accumulated Other Comprehensive Income	-0.96	-0.84	-0.89	-0.83	-1.25	-1.46	-1.95	-1.86	1.10	1.29
Additional Paid-in Capital	451.70	326.31	238.40	168.92	152.45	151.58	128.83	127.33	0.00	31.43
Shares Outstanding	34.42	26.25	10.09	1.65	0.48	-	-	-	-	-
Total Stockholders' Equity	177.01	97.30	47.25	0.20	2.88	20.01	10.24	16.57	13.77	21.58
Total Liabilities & Equity	182.62	99.59	52.21	4.46	5.97	21.38	11.74	19.21	15.68	17.42

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Benitec Biopharma Balance Sheet

How much debt does Benitec Biopharma have?

Benitec Biopharma had total debt of $762.00K as of Jun 30, 2026, against $179.97M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $849.00K a year earlier.

What are Benitec Biopharma's total assets?

Benitec Biopharma reported total assets of $182.62M as of Jun 30, 2026, up 83.4% from $99.59M a year earlier. Total liabilities were $5.61M.

What is Benitec Biopharma's shareholders' equity?

Benitec Biopharma's shareholders' equity was $177.01M as of Jun 30, 2026, or about $5.14 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition